Results 191 to 200 of about 452,213 (327)

Desmoplastic melanoma in Sweden in 2009–2022: A population‐based registry study demonstrating distinctive tumour characteristics, incidence and survival trends

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page 90-98, January 2026.
The incidence of desmoplastic melanoma (DM) in Sweden remains stable, unlike rising cutaneous melanoma rates. Despite advanced tumour features, DM patients have better survival outcomes. However, recent survival improvements are lacking, potentially due to limited treatment options compared to other melanoma subtypes.
Yodit Girmay   +5 more
wiley   +1 more source

V-Notes Sentinel Lymph Node Staging for Endometrial Cancer: A Systematic Review. [PDF]

open access: yesJ Clin Med
Nădăban M   +5 more
europepmc   +1 more source

Clinical, pathological and prognostic features of surgically excised cutaneous and subcutaneous digital and distal limb mast cell tumours in dogs

open access: yesJournal of Small Animal Practice, Volume 67, Issue 1, Page 67-76, January 2026.
Objective To evaluate clinical, pathological and prognostic features and outcomes of dogs with surgically excised cutaneous and subcutaneous digital or distal limb mast cell tumours. Materials and Methods Medical records between 2014 and 2024 were reviewed, and signalment, clinicopathological testing, tumour location, recurrence, complications and ...
A. K. Erickson   +4 more
wiley   +1 more source

The Major Role of Type 2 Inflammation in Asthma: From the Perspective of Immunological Mechanism

open access: yesBioMed Research International, Volume 2026, Issue 1, 2026.
Asthma is a heterogeneous disease that affects individuals of diverse age groups globally and exhibits variable responses to different treatments. Type 2 inflammation contributes to the pathogenesis of asthma through the production of cytokines IL‐4, IL‐5, and IL‐13, thereby inducing characteristic features of asthma such as elevated eosinophil levels ...
Lanying Cheng   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy